AAM Backs Bill To Boost Biosimilar Reimbursement

Proposed Legislation Would Temporarily Increase Rate To Average Sales Price Plus 8%

8% Dollars Stack
The bill would raise biosimilar reimbursement to the ASP +8% • Source: Alamy

More from Biosimilars

More from Products